Tunable, monochromatic x-rays: An enabling technology for molecular/cellular imaging and therapy

Journal of Cellular Biochemistry

Volumn 90, Issue 3, 2003, Pages 502-508

  Carroll, Frank ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Auger cascade; Crystallography; K edge; Mammography; Monochromatic X rays

Indexed keywords

CONTRAST MEDIUM; CYCLOOXYGENASE 2; DEXTRAN; FLUOROCARBON; GADOLINIUM; IMMUNOLIPOSOME; IODINATED CONTRAST MEDIUM; IODINE; IRON OXIDE; NANOPARTICLE; P 760; POLYMER; PORPHYRIN DERIVATIVE; PV 10; ROSE BENGAL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XENON;

COLOR; CRYSTALLOGRAPHY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ELECTRON; IMAGING SYSTEM; MAMMOGRAPHY; MICELLE; MONOCHROMATIC X RAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHLEBOGRAPHY; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; X RAY;

ANIMALS; BREAST NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; MICE; OSTEOPOROSIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA;

EID: 0141885262     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10632     Document Type: Review

References (29)

1. Arteaga CL, Chinratanalab W, Carter MB. 2001. Inhibitors of HER2/neu (erbB-2) signal transduction. Semin Oncol 28(Suppl 18):30-35.
2. Boone JM. 1999. Glandular breast dose for monoenergetic and high energy X-ray beams: Monte Carlo assessment. Radiology 213:23-37.
3. Boone JM, Nelson TR, Lindfors KK, Seibert JA. 2001. Dedicated breast CT: Radiation dose and image quality evaluation. Radiology 221:657-667.
4. Carroll FE. 2002. Perspectives. Tunable, monochromatic X-rays: A new paradigm in medicine. AJR 179:583-590.
5. Carroll FE, Waters JW, Price RR, Brau CA, Roos CF, Tolk NH, Pickens DR, Stephens WH. 1990. Near-monochromatic X-ray beams produced by the free electron laser and compton backscatter. Invest Radiol 25:465-471.
6. Carroll FE, Waters JW, Andrews WW, Price RR, Pickens DR, Willcott R, Tompkins P, Roos C, Page D, Reed G, Ueda A, Bain R, Wang P, Bassinger M. 1994. Attenuation of monochromatic X-rays by normal and abnormal breast tissues. Invest Radiol 29:266-272.
7. Carroll FE, Waters JW, Traeger RH, Mendenhall MH, Clark WW, Brau DA. 1999. Production of tunable, monochromatic X-rays by the Vanderbilt free-electron laser. Proceedings SPIE. Free Electron Laser Challenges II 3614:139-146.
8. Carroll FE, Mendenhall MH, Traeger RH, Brau C, Waters JW. 2003. Pulsed, tunable, monochromatic X-rays from a compact source: New opportunities. AJR (in press).
9. Cho JY, Shen DHY, Yang W, Williams B, Buckwalter TLF, La Perle KMD, Hinkle G, Pozderac R, Kloos R, Nagaraja HN, Barth RF, Jhiang SM. 2002. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas. Gene Ther 9:1139-1145.
10. Dix WR. 1995. Intravenous coronary angiography with synchrotron radiation. Prog Biophys Mol Biol 63:159-191.
11. Dix WR, Kupper W, Dill T, Hamm CW, Job H, Lohmann M, Reime B, Ventura R. 2003. Comparison of intravenous coronary Angiography using synchrotron radiatiobn with selective coronary Angiography. J Synchrotron Rad 10:219-227.
12. DuBois RN, Radhika A, Reddy BS, Entingh AJ. 1996. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Am J Gastroenterol 110:1259-1262.
13. Gordon R, Sivaramakrishna R. 1999. Mammograms are waldograms: Why we need 3-D longitudinal breast screening. Appl Radiol 28:12-25.
14. Harteman FV, Baldis HA, Kerman AK, Le Foll A, Luhmann NC, Rupp B. 2001. Three-dimensional theory of emittance in Compton scattering and X-ray protein crystallography. Phys Rev E 64:016501-1-016501-26.
15. Johns PC, Yaffe MJ. 1987. X-ray characterization or normal and neoplastic breast tissues. Phys Med Biol 32:675-695.
16. Karnas SJ, Edward Y, McGarry RC, Battista JJ. 1999. Optimal photon energies for IUdR k-edge radiosensitization with filtered X-ray and radioisotope sources. Phys Med Biol 44:2537-2549.
17. Kassis AI, Sastry KSR, Adelstein SJ. 1987. Kinetics of uptake, retention and raeiotoxicity of 125 IUDR in mammalian cells: Implications of localized energy deposition by Auger processes. Rad Res 109:78-89.
18. Kimme-Smith C. 1999. New digital mammography systems may require different X-ray spectra and therefore, more general normalized glandular dose values. Radiology 213:7-10.
19. Kroft LJ, Doornbos J, van der Geest RJ, Benderbous S, de Roos A. 1999. Infarcted myocardium in pigs: MR imaging enhanced with slow-interstitial-diffusion gadolinium compound P760. Radiololgy 212:467-473.
20. Lee FT, Chosy SF, Naidu SF, Goldfarb S, Weichert JP, Bakan DA, Kuhlman JE, Tambeaux RH, Sproat IA. 1997. CT depiction of experimental liver tumors: Contrast enhancement with hepatocyte-selective iodinated triglycerides versus conventional techniques. Radiology 203:465-470.
21. Miller RA, Woodburn K, Fan Q, Renschler MF, Sessler JL, Koutcher JA. 1999. In vivo animal studies with gadolinium (III) texaphyrin as a radiatioin enhancer. Int J Radiat Oncol Biol Phys 45:981-989.
22. Moore A, Marecos E, Bogdanov A, Weissleder R. 2000. Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568-574.
23. Mullan BF, Madsen MT, Messerle L, Kolesnichenko V, Kruger J. 2000. X-ray attenuation coefficients of high-atomic-number, hexanuclear transition metal cluster compounds: A new paradigm for radiographic contrast agents. Acad Radiol 7(4):254-259.
24. Ohtsuka S, Sugishita Y, Hyodo K. 1994. Intravenous coronary angiography using a two dimensional imaging system. Synchrotron Radiat News 7:21-22.
25. Pignol JP, Rakovitch E, Beachey D, Sech CL. 2003. Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds. Int J Radiat Oncol Biol Phys 55(4):1082-1091.
26. Rubenstein E, Giacomini JC, Gordon HJ, Rubenstein JAL, Brown G. 1995. Xenon k-edge dicromographic bronchography: synchrotron radiation based medical imaging. Nucl Instrum Methods A 364:360-361.
27. Spitzweg C, Dietz AB, O'Connor MK, Bergert ER, Tindall DJ, Young CYF, Morris JC. 2001. In vivo sodium iodide symporter gene therapy of prostate cancer. Gene Ther 8:1524-1531.
28. Torchilin VP, Frank-Kamenetsky MD, Wolf GL. 1999. CT visualization of blood pool in rats by using long-circulating, iodine-containing micelles. Acad Radiol 6(1):61-65.
29. 4. Med Phys 25(5):709-718.